Bill
HR 3162
The Affordable and Safe Prescription Drug Importation Act allows licensed pharmacists to import safe, affordable medications, aiming to lower drug costs for consumers.
The Affordable and Safe Prescription Drug Importation Act of 2025 (HR 3162) aims to address the rising costs of prescription medications in the United States by allowing the importation of prescription drugs from certain countries. The bill seeks to enhance access to affordable medications while ensuring safety and efficacy for consumers.
The bill includes several important provisions:
Importation Authorization: The legislation permits licensed pharmacists and wholesalers to import prescription drugs from countries that meet specific safety and regulatory standards, primarily focusing on nations with robust pharmaceutical regulations.
Safety Standards: To ensure the safety of imported drugs, the bill mandates that imported medications must comply with the same safety and efficacy standards as those required for drugs sold in the U.S.
Regulatory Oversight: The bill requires the Secretary of Health and Human Services (HHS) to establish a regulatory framework for the importation process, including guidelines for the approval of foreign suppliers and the monitoring of imported drugs.
Consumer Protection: Provisions are included to protect consumers from counterfeit drugs, ensuring that all imported medications are verified and authenticated before reaching the U.S. market.
Cost Savings: The bill aims to provide significant cost savings for consumers by increasing competition in the pharmaceutical market, potentially lowering prices for prescription medications.
Consumers: Patients who rely on prescription medications would benefit from potentially lower prices and increased access to affordable drugs.
Pharmacists and Wholesalers: Licensed pharmacists and wholesalers would gain the ability to import drugs, expanding their business opportunities and product offerings.
Pharmaceutical Companies: Domestic pharmaceutical manufacturers may face increased competition from imported drugs, which could influence pricing strategies and market dynamics.
Introduced Date: The bill was introduced in the House on May 1, 2025.
Committee Referral: Following its introduction, HR 3162 was referred to the House Committee on Energy and Commerce for further consideration.
Next Steps: The bill will undergo discussions and potential amendments within the committee before it can be brought to the House floor for a vote.
The Affordable and Safe Prescription Drug Importation Act of 2025 represents a significant legislative effort to tackle the issue of high prescription drug prices in the U.S. By allowing the importation of drugs from select countries, the bill aims to enhance affordability and access while maintaining strict safety standards. As it progresses through the legislative process, its implications for consumers, healthcare providers, and the pharmaceutical industry will be closely monitored.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
